It is a triple receptor agonist acting on GLP-1, GIP, and glucagon receptors, distinguishing it from currently approved dual or single agonists
During GLP-1 use, especially for weight reduction, appetite is regulated: food moves through the stomach more slowly, fullness signals last longer, and hunger hormones are controlled
Claim Your Free Consultation Submit your information below and a member of our team will reach out to you
This is the defining feature of a secretagogue , and it is central to how these peptides are discussed
If the legislation becomes law, Kentucky will join 33 other states with similar laws
GLP-1RAs have reliable hypoglycaemic and weight-loss effects that can intervene in obesitythe basis of type 2 diabetes pathologyand multifaceted effects on other cardiometabolic parameters, such as blood pressure and circulating lipids [21]